Page last updated: 2024-08-24

imiquimod and Local Neoplasm Recurrence

imiquimod has been researched along with Local Neoplasm Recurrence in 121 studies

Research

Studies (121)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's31 (25.62)29.6817
2010's63 (52.07)24.3611
2020's27 (22.31)2.80

Authors

AuthorsStudies
Jiang, J; Kuai, L; Li, B; Li, X; Liu, T; Luo, Y; Ru, Y; Song, J; Sun, X; Xing, M; Zhang, H1
Jonnalagadda, S; Palle, K; Reedy, M1
Álvarez-Chinchilla, P; Bañuls-Roca, J; Hispán-Ocete, P; Poveda-Montoyo, I; Schneller-Pavelescu, L2
Hou, JJ; Jia, HY; Qiu, HY; Wu, Y; Zhang, MD; Zhou, ML1
Liu, X; Wang, C; Yang, Z; Zhang, D; Zhang, J; Zhao, M; Zhou, C; Zhu, S1
Bedane, C; Bens, G; Beylot-Barry, M; Bossard, C; Daude, M; Debarbieux, S; Denis, MG; Dinulescu, M; Dréno, B; Khammari, A; Le Duff, F; Leccia, MT; Legoupil, D; Machet, L; Maillard, H; Meyer, N; Monestier, S; Nguyen, JM; Vergier, B; Wierzbicka-Hainaut, E1
Javed, MU; Kaur, A; Murison, M; Venables, B; Yarrow, J1
Cao, X; Xue, R; Yuan, X1
Gou, M; Huang, M; Huang, Y; Kang, T; Li, Y; Liu, J; Wang, S; Wang, Y; Wei, X; Xiong, M; Yang, L; Zhu, J1
Kulakov, EL; Logan, IT; Perrett, CM1
Arits, AHMM; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Sinx, KAE; Winnepenninckx, VJL1
Carnevale, C; D'Argenio, P; Diociaiuti, A; El Hachem, M; Giancristoforo, S; Lucchetti, MC; Rotunno, R; Tchidjou, HK1
Haidopoulos, D; Pergialiotis, V; Rodolakis, A; Rountis, A; Tsetsa, P1
Bartenjev, I; Bartenjev, MS; Isaković-Vidović, S1
Carton, I; Henno, S; Lavoué, V; Lebreton, M; Levêque, J; Nyangoh-Timoh, K; Tesson, C1
Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U1
Bath-Hextall, FJ; Hogan, S; Leonardi-Bee, J; Thomson, J; Williams, HC2
Choi, S; Chung, KY; Oh, BH; Oh, Y; Roh, MR1
Badiavas, EV; Gonzalez, AM; Kirsner, RS; Moore, K; Nagrani, N; Nahm, WJ; Nichols, AJ; Shen, J; Zito, PM1
Baker, C; Chambers, M; Chapman, MS; Saunders, E; Swetter, SM1
Piqué-Duran, E1
Catorze, G; Labareda, J; Miroux Catarino, A; Queirós, C; Silva, L; Viana, I1
Giacomantonio, CA; Helyer, LK; Pasternak, S; Peltekian, K; Simms, GA; Stein, J; Vidovic, D; Walsh, M1
Bennardo, L; Cisale, GY; Nisticò, SP; Pentangelo, G; Provenzano, E1
Bennardo, F; Bennardo, L; Dastoli, S; Giudice, A; Morrone, P; Nisticò, SP; Passante, M; Patruno, C; Provenzano, E1
Ahmed, E; El-Khalawany, M; Mosbeh, A; Rageh, MA; Sameh, A; Saudi, WM1
Chapman, MS; Park, AJ; Paul, J; Samie, FH1
Baldelli, F; Cavazzoni, E; Leo, CA; Santorelli, C1
Hutson, R; Nama, V; Parashurama, R1
Dressler, C; Nast, A; Werner, RN; Westfechtel, L1
Bostanci, S; Botsali, A; Heper, AO; Kocyigit, P; Vural, S1
Carucci, M; Fiander, A; Hurt, CN; Jones, S; Madden, TA; Naik, R; Nordin, AJ; Powell, N; Tristram, A1
Shaw, FM; Weinstock, MA1
Helm, CW1
Bowen, GM; Bowling, M; Donigan, JM; Goldgar, DE; Hadley, ML; Hyde, MA1
Fosko, SW; Navarrete-Dechent, CP; Nehal, KS1
Collier, NJ; Exton, LS; Green, AC; Haylett, AK; Ibbotson, SH; Mallipeddi, R; McKenna, KE; Mohd Mustapa, MF; Morton, CA; Moseley, H; Rhodes, LE; Seukeran, D; Ward, KA; Wong, TH1
Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJM; van Kemenade, FJ1
Delman, KA; Farley, CR; Lopez-Aguiar, AG; Lowe, MC; Oh, G; Russell, MC1
Bulten, J; de Hullu, JA; Fons, G; Lok, CAR; Massuger, LFAG; Oonk, MHM; Slangen, BMF; van der Linden, M; van Doorn, HC; van Dorst, EBL; van Poelgeest, MIE1
Brand, FL; Hunger, RE; Seyed Jafari, SM1
Innamaa, A; Lippiatt, J; Melson, L; Mujukian, A1
Bouceiro-Mendes, R; Correia-Fonseca, I; Mendonça-Sanches, M; Soares-de-Almeida, L1
Bassett, RL; Chon, S; Fox, PS; McKay, KM; Prieto, VG; Sambrano, BL1
Assorgi, C; Biamonti, A; Catalano, A; Cozza, G; Frega, A; Gentile, M; Lombardi, D; Maniglio, P; Marziani, R; Milazzo, GN; Moscarini, M; Ricciardi, E; Scirpa, P; Sesti, F; Sopracordevole, F1
Bassukas, ID; Gaitanis, G1
Nelson, EL; Stockdale, CK1
Bath-Hextall, FJ; Leonardi-Bee, J; Matin, RN; Wilkinson, D1
Bassukas, ID; Nakuçi, M1
Chen, FP1
Buttmann, N; Clad, A; Gieseking, F; Harter, P; Lellé, RJ; Luyten, A; Maass-Poppenhusen, K; Petry, KU; Sörgel, P1
Jiayuan, C; Jing, W; Juan, X; Li, X; Qin, H; Qing, L; Shengmei, X1
Bassukas, ID; Gaitanis, G; Kempf, W; Markatseli, TE; Voulgari, PV1
Biamonti, A; Bianchi, P; Caserta, D; Catalano, A; Cozza, G; Di Martino, G; Frega, A; Gentile, M; Marziani, R; Milazzo, GN; Schimberni, M; Scirpa, P; Sesti, F; Sopracordevole, F; Zinna, M1
Gao, X; Geng, L; Shi, J; Wang, H; Xu, Y1
den Hollander, JC; van der Ende, ME; van der Snoek, EM1
Carneiro, RC; de Lima, PP; de Macedo, EM; Matayoshi, S; Silva, BG1
Cohen, JL; Friedman, A; Ruiz, ES1
Karia, PS; Mora, AN; Nguyen, BM1
Barlow, R; Coleman, A; Craythorne, EE; Kai, AC; Mallipeddi, R; Richards, T1
Baumgartner, M; Gadaldi, K; Gautschi, M; Hunger, RE; Oberholzer, PA; Yawalkar, N1
de Vries, K; Greveling, K; Prens, EP; van Doorn, MB1
Bryant, A; Chakrabarti, M; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L1
Abu-Rustum, NR; Backes, FJ; Black, DR; Chi, DS; Cowan, RA; Eisenhauer, EL; Gardner, GJ; Hoang, LN; Leitao, MM; Park, KJ; Soslow, RA1
Arits, AHMM; de Rooij, MJM; Essers, BAB; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM1
Armstrong, SJ; Bath-Hextall, F; Colver, GB; Miller, PSJ; Ozolins, M; Perkins, W; Williams, HC1
Hoekzema, R; Jansma, EP; Prinsen, CAC; Tio, D; van der Woude, J; van Montfrans, C1
Gioia Di Chiacchio, N; Haneke, E; le Voci, F; Ocampo-Garza, J; Paschoal, FM1
Affleck, AG; Evans, A; Ezughah, FI; Fleming, CJ; Ibbotson, SH1
Geisler, JP; Manahan, KJ1
Carroll, S; Czarnecki, C; Czarnecki, D1
Balkrishnan, R; Feldman, SR; Karve, SJ; Pearce, DJ; Yentzer, BA1
Baer, KE; Bergman, PJ; Craft, D; Gill, VL; Leung, C1
McCall, MW; Woodmansee, CS1
Brightman, L; Daniel, DR; Geronemus, RG; Mahlberg, MJ; Mintzis, MM; Sukal, SA1
Cordoro, KM; Greer, KE; Lonergan, CL; McNamara, EK1
Bertozzi, S; Fruscalzo, A; Lellé, RJ; Londero, AP; Marchesoni, D1
De'Ambrosis, B; Gebauer, K; Meng, TC; Quirk, C; Slade, HB1
Ayers, D; Kenealy, J; O'Neill, J1
Güngor, T; Ozat, M; Sahin, I; Sirvan, L; Tonguc, E; Var, T1
Bordeaux, JS; Capaldi, L; Maloney, ME; Martires, KJ; Pattee, SF1
Bruckner-Tuderman, L; Burger, B; Has, C; Itin, P; Kohlhase, J; Volz, A1
Aguayo-Leiva, IR; Jaén-Olasolo, P; Ríos-Buceta, L1
Borden, E; Triozzi, PL; Tuthill, RJ1
Gil-Bistes, D; Guillot, B; Kluger, N; Rigau, V1
Caminal, JM; Fabra, A; Ferreres, JR; Marcoval, J; Penín, RM; Piulats, JM1
Badiglian-Filho, L; Baiocchi, G; Begnami, MD; Costa, FD; Faloppa, CC; Fukazawa, EM; Kumagai, LY; Oliveira, RA; Soares, FA; Surima, WS1
Bogatch, K; Carvajal, RD; Chapman, PB; Chi, DS; Costantino, PD; Flavin, M; Gardner, GJ; Pulitzer, MP; Schwartz, GK; Smyth, EC; Wolchok, JD1
Chu, J; Hartman, R; Meehan, S; Patel, R; Stein, JA1
Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C1
Borrego, J; Figueiredo, A; Paula, T; Ribeiro, F1
Guillén, C; Hilari, H; Llombart, B; Llorca, D; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V; Villanueva, A1
Brown, J; Frumovitz, M; Milbourne, AM; Munsell, MF; Rhodes, HE; Schmeler, KM; Trimble, CL; Wallbillich, JJ1
Brodell, RT; Tandon, Y1
Adams, S; Babb, JS; Demaria, S; Dewan, MZ; DiNapoli, S; Formenti, SC; Kawashima, N; Vanpouille-Box, C1
Clad, A; Fischer, A; Westermann, C1
Binder, B; Cerroni, L; Kerl, H; Richtig, E; Smolle, J; Wolf, IH1
Awada, A; Heenen, M; Laporte, M; Mathieu, A; Petein, M; Velu, T; Vereecken, P1
Epstein, E1
Fisher, GH; Lang, PG1
Blanchard, A; Busbey, S; Judge, DE; Lorincz, AA; Medenica, MM; Wang, LC1
Beyeler, M; Burg, G; Dummer, R; Morcinek, J1
Aebi, S; Caversaccio, M1
Kerl, H; Kopera, D; Richtig, E; Wolf, IH1
Bauer, J; Eigentler, TK; Garbe, C; Kamin, A; Radny, P; Weide, B1
Markus, J; Orengo, I; Pielop, JA; Rivera, A1
Ceilley, RI; Del Rosso, JQ1
Diaz, SF; Gilbert, S; Jessen, C; Malone, ED; Nogueira, SA; Torres, SM1
Gebauer, K; Owens, M; Quirk, C; Stampone, P1
Li, LJ; Wagamon, K1
Bodman-Smith, MD; Dalgleish, AG; Fischer, MD; Green, DS1
Kirtschig, G; van Doorn, R; van Meurs, T1
Carroll, MT; Tillman, DK2
Offner, F; Schiessl, C; Strohal, R; Tauber, M; Wolber, C1
Fenske, NA; Glass, LF; Prakash, AV; Shistik, G1
Ely, H; Rigel, DS; Torres, AM1
Davis, G; Richard, J; Wentworth, J1
Jayne, CJ; Kaufman, RH1

Reviews

23 review(s) available for imiquimod and Local Neoplasm Recurrence

ArticleYear
Network meta-analysis of treatments for perineal extramammary paget's disease: Focusing on performance of recurrence prevention.
    PloS one, 2023, Volume: 18, Issue:11

    Topics: Bayes Theorem; Female; Humans; Imiquimod; Male; Mohs Surgery; Neoplasm Recurrence, Local; Network Meta-Analysis; Paget Disease, Extramammary; Retrospective Studies

2023
Management options for vaginal intraepithelial neoplasia.
    International journal of clinical practice, 2020, Volume: 74, Issue:11

    Topics: Carcinoma in Situ; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Retrospective Studies; Vaginal Neoplasms

2020
Paget's disease of the vulva: A challenge for the gynaecologist.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:1

    Topics: Administration, Topical; Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Imiquimod; Lasers, Gas; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photochemotherapy; Prognosis; Radiotherapy Dosage; Vulvar Neoplasms

2021
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
    International journal of colorectal disease, 2021, Volume: 36, Issue:2

    Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections

2021
Interventions for basal cell carcinoma of the skin.
    The Cochrane database of systematic reviews, 2020, 11-17, Volume: 11

    Topics: Adult; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Female; Humans; Imiquimod; Immunocompetence; Laser Therapy; Male; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome

2020
Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments.
    The British journal of dermatology, 2021, Volume: 185, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult

2021
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Graft Rejection; Humans; Imiquimod; Immunocompromised Host; Immunosuppression Therapy; Infusions, Intralesional; Interleukin-2; Kidney Transplantation; Liver Transplantation; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Transplant Recipients; Treatment Outcome

2021
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
    Current oncology (Toronto, Ont.), 2021, 06-23, Volume: 28, Issue:4

    Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms

2021
Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
    Sexually transmitted infections, 2017, Volume: 93, Issue:8

    Topics: Aminoquinolines; Antiviral Agents; Anus Diseases; Coinfection; Female; Genital Diseases, Female; Genital Diseases, Male; HIV Seropositivity; Humans; Imiquimod; Immunocompetence; Male; Neoplasm Recurrence, Local; Papillomavirus Infections; Randomized Controlled Trials as Topic; Warts

2017
Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    The British journal of dermatology, 2018, Volume: 179, Issue:6

    Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Dose Fractionation, Radiation; Esthetics; Humans; Imiquimod; Neoplasm Recurrence, Local; Pain; Pain Measurement; Patient Safety; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome

2018
Interventions for cutaneous Bowen's disease.
    The Cochrane database of systematic reviews, 2013, Jun-24, Issue:6

    Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cryotherapy; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome

2013
Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.
    Photodermatology, photoimmunology & photomedicine, 2015, Volume: 31, Issue:1

    Topics: Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Incidence; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms; Time Factors

2015
Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:5

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms

2015
A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance.
    Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Assessment; Skin Neoplasms; Survival Rate; Treatment Outcome

2015
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
    The Cochrane database of systematic reviews, 2016, Jan-05, Issue:1

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Disease Progression; Female; Humans; Imiquimod; Indoles; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Photochemotherapy; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms

2016
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:4

    Topics: Aminoquinolines; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Skin Neoplasms

2017
Imiquimod: a review of basal cell carcinoma treatments.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:11

    Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Mohs Surgery; Neoplasm Recurrence, Local; Neoplasms, Basal Cell; Quality of Life; Skin Neoplasms

2008
[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].
    Gynakologisch-geburtshilfliche Rundschau, 2009, Volume: 49, Issue:4

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Chemotherapy, Adjuvant; Colposcopy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulva; Vulvar Neoplasms

2009
Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature.
    Archives of gynecology and obstetrics, 2011, Volume: 283, Issue:1

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Betamethasone; Emollients; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Treatment Outcome; Vulvar Neoplasms

2011
Extramammary Paget disease.
    Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10

    Topics: Aminoquinolines; Antineoplastic Agents; Asian People; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnostic Errors; Eczema; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Skin Neoplasms

2011
Local reactions to imiquimod in the treatment of basal cell carcinoma.
    Dermatology online journal, 2012, Sep-15, Volume: 18, Issue:9

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Keratosis, Actinic; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2012
[Cutaneous neoplasms].
    Praxis, 2003, Sep-03, Volume: 92, Issue:36

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors

2003
Current modalities and new advances in the treatment of basal cell carcinoma.
    International journal of dermatology, 2006, Volume: 45, Issue:5

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Curettage; Electrosurgery; Humans; Imiquimod; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms

2006

Trials

18 trial(s) available for imiquimod and Local Neoplasm Recurrence

ArticleYear
Efficacy of imiquimod in the management of lentigo maligna.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2023, Volume: 37, Issue:9

    Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms

2023
Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial.
    Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Dermatologic Surgical Procedures; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Skin; Skin Cream; Skin Neoplasms

2020
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).
    BJOG : an international journal of obstetrics and gynaecology, 2018, Volume: 125, Issue:9

    Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Vulvar Neoplasms

2018
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
    BMC cancer, 2018, Jun-15, Volume: 18, Issue:1

    Topics: Adult; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Research Design; Single-Blind Method; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2018
Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter.
    Acta dermato-venereologica, 2014, Volume: 94, Issue:1

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden

2014
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.
    BMC ophthalmology, 2015, Apr-03, Volume: 15

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Prospective Studies; Skin Cream; Treatment Outcome

2015
Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study.
    Journal of the American Academy of Dermatology, 2016, Volume: 74, Issue:1

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Biopsy, Needle; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Male; Melanocytes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Switzerland; Time Factors; Treatment Outcome

2016
A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease.
    Gynecologic oncology, 2016, Volume: 142, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Pilot Projects

2016
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Proportional Hazards Models; Single-Blind Method; Skin Neoplasms; Treatment Outcome

2016
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.
    The Journal of investigative dermatology, 2017, Volume: 137, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Child; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult

2017
Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.
    The Journal of dermatological treatment, 2008, Volume: 19, Issue:3

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Histocytological Preparation Techniques; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin; Skin Neoplasms; Treatment Outcome

2008
Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.
    Cutis, 2010, Volume: 85, Issue:6

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Outcome

2010
Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study.
    Veterinary dermatology, 2006, Volume: 17, Issue:4

    Topics: Administration, Cutaneous; Aminoquinolines; Animals; Antineoplastic Agents; Female; Horse Diseases; Horses; Imiquimod; Male; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome

2006
Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
    The Australasian journal of dermatology, 2006, Volume: 47, Issue:4

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; New Zealand; Severity of Illness Index; Skin Neoplasms; Treatment Outcome

2006
Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
    The British journal of dermatology, 2007, Volume: 156, Issue:2

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Ointments; Skin Neoplasms; Treatment Outcome

2007
Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
    Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:5

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2007
Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Desiccation; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2008
A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Electrosurgery; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms

2008

Other Studies

80 other study(ies) available for imiquimod and Local Neoplasm Recurrence

ArticleYear
TMT-based proteomics analysis reveals the protective effect of Jueyin granules on imiquimod-induced psoriasis mouse model by causing autophagy.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 96

    Topics: Animals; Autophagy; Disease Models, Animal; Humans; Imiquimod; Mice; Neoplasm Recurrence, Local; Proteomics; Psoriasis

2022
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients.
    Pathology oncology research : POR, 2021, Volume: 27

    Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections; Salvage Therapy; Toll-Like Receptor 7

2021
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
    Actas dermo-sifiliograficas, 2022, Volume: 113, Issue:4

    Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms

2022
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
    Actas dermo-sifiliograficas, 2022, Volume: 113, Issue:4

    Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms

2022
Lenalidomide attenuates IMQ-induced inflammation in a mouse model of psoriasis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156

    Topics: Animals; Disease Models, Animal; Imiquimod; Inflammation; Lenalidomide; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Skin; Tumor Microenvironment

2022
Long-lasting postoperative analgesia with local anesthetic-loaded hydrogels prevent tumor recurrence via enhancing CD8
    Journal of nanobiotechnology, 2023, Feb-10, Volume: 21, Issue:1

    Topics: Analgesia; Anesthetics, Local; CD8-Positive T-Lymphocytes; Humans; Imiquimod; Neoplasm Recurrence, Local; Pain, Postoperative; Quality of Life; Ropivacaine; T-Lymphocytes

2023
Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2023, Volume: 85

    Topics: Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lasers, Gas; Longitudinal Studies; Neoplasm Recurrence, Local; Skin Neoplasms

2023
Modular Engineering of Targeted Dual-Drug Nanoassemblies for Cancer Chemoimmunotherapy.
    ACS applied materials & interfaces, 2019, Oct-09, Volume: 11, Issue:40

    Topics: Animals; Antigen Presentation; Apoptosis; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Drug Therapy; Female; Imiquimod; Immunotherapy; Mice, Inbred BALB C; Nanoparticles; Neoplasm Recurrence, Local; Neoplasms; Paclitaxel; Rats, Sprague-Dawley; Tissue Distribution

2019
Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020, Volume: 46, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Esthetics; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome

2020
Successful topical treatment of anal giant condylomata acuminata in an infant.
    Dermatologic therapy, 2020, Volume: 33, Issue:4

    Topics: Administration, Topical; Aminoquinolines; Child; Condylomata Acuminata; Humans; Imiquimod; Infant; Neoplasm Recurrence, Local

2020
Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
    Acta dermatovenerologica Croatica : ADC, 2020, Volume: 28, Issue:1

    Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms

2020
Initial topical monotherapy may increase the risk of recurrence in patients with extramammary Paget's disease.
    The Journal of dermatology, 2021, Volume: 48, Issue:5

    Topics: Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Retrospective Studies

2021
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
    Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cost-Benefit Analysis; Cryotherapy; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tretinoin

2021
Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up.
    Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratolytic Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Nicotinic Acids; Prospective Studies; Retrospective Studies; Skin Neoplasms; Time Factors

2021
Recurrence of a Basal Cell Carcinoma in a Vitiligo-like Area After Imiquimod Treatment.
    Actas dermo-sifiliograficas, 2021, Volume: 112 Suppl 1

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome; Vitiligo

2021
Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study.
    The British journal of dermatology, 2021, Volume: 185, Issue:4

    Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome

2021
Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.
    Medicina (Kaunas, Lithuania), 2021, Jun-02, Volume: 57, Issue:6

    Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Humans; Imiquimod; Lip; Neoplasm Recurrence, Local; Papillomavirus Infections

2021
The combined effect of CO
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:5

    Topics: Antineoplastic Agents; Carbon Dioxide; Carcinoma, Basal Cell; Diclofenac; Female; Humans; Imiquimod; Lasers, Gas; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2022
Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2017, Volume: 43, Issue:8

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Imiquimod; Male; Melanoma; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome

2017
Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients.
    Sexually transmitted infections, 2017, Volume: 93, Issue:3

    Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Italy; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome

2017
Paget's Disease of the Vulva: A Review of 20 Years' Experience.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms

2017
Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:1

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Cream; Skin Neoplasms; Time Factors

2018
Comparing Topical Treatments for Basal Cell Carcinoma.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:3

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms

2018
Is cidofovir a better treatment than imiquimod for high-grade vulval intraepithelial neoplasia?
    BJOG : an international journal of obstetrics and gynaecology, 2018, Volume: 125, Issue:9

    Topics: Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Vulvar Neoplasms

2018
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
    JAMA dermatology, 2018, 08-01, Volume: 154, Issue:8

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Nicotinic Acids; Off-Label Use; Retrospective Studies; Skin Neoplasms; Treatment Outcome

2018
Lentigo Maligna-Challenges, Observations, Imiquimod, Confocal Microscopy, and Personalized Treatment.
    JAMA dermatology, 2018, 08-01, Volume: 154, Issue:8

    Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Off-Label Use; Skin Neoplasms

2018
Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma
    The American surgeon, 2018, Aug-01, Volume: 84, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Margins of Excision; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms

2018
Vulvar Paget disease: A national retrospective cohort study.
    Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Netherlands; Paget Disease, Extramammary; Retrospective Studies; Survival Rate; Vulvar Neoplasms; Vulvectomy

2019
Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy.
    Dermatology (Basel, Switzerland), 2019, Volume: 235, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Contraindications, Procedure; Dermatologic Surgical Procedures; Dermoscopy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome

2019
Extensive extramammary Paget's disease of the vulva involving the bladder postradical split skin graft reconstruction.
    BMJ case reports, 2019, Mar-09, Volume: 12, Issue:3

    Topics: Aged, 80 and over; Antineoplastic Agents; Cystoscopy; Female; Gynecologic Surgical Procedures; Humans; Imiquimod; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Transplantation; Urethral Neoplasms; Urinary Bladder Neoplasms; Vulvar Neoplasms

2019
A Case of Chronic and Relapsing Paget Disease of the Vulva.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2019, Volume: 41, Issue:6

    Topics: Aged; Antineoplastic Agents; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Plastic Surgery Procedures; Treatment Outcome; Vulvar Neoplasms; Vulvectomy

2019
Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC.
    The British journal of dermatology, 2013, Volume: 169, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Failure; Treatment Outcome

2013
Imiquimod 5% cream versus cold knife excision for treatment of VIN 2/3: a five-year follow-up.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:7

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Ointments; Vulvar Neoplasms

2013
Vulvar and vaginal HPV disease.
    Obstetrics and gynecology clinics of North America, 2013, Volume: 40, Issue:2

    Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colposcopy; Condylomata Acuminata; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Middle Aged; Neoplasm Recurrence, Local; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Trichloroacetic Acid; Vaginal Diseases; Vaginal Neoplasms; Vaginal Smears; Vulvar Diseases; Vulvar Neoplasms; Young Adult

2013
Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy.
    Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2013, Volume: 22, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Ambulatory Care; Aminoquinolines; Carcinoma, Basal Cell; Cohort Studies; Cryosurgery; Feasibility Studies; Female; Follow-Up Studies; Greece; Humans; Imiquimod; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Office Visits; Risk Assessment; Skin Neoplasms; Treatment Outcome

2013
Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
    Taiwanese journal of obstetrics & gynecology, 2013, Volume: 52, Issue:4

    Topics: Aminoquinolines; Antineoplastic Agents; Cervix Uteri; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Papanicolaou Test; Papillomavirus Infections; Retrospective Studies; Severity of Illness Index; Time Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina; Vaginal Neoplasms; Vaginal Smears

2013
Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network.
    Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Cohort Studies; Colposcopy; Female; Follow-Up Studies; Germany; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paget Disease, Extramammary; Retrospective Studies; Risk Assessment; Survival Rate; Treatment Outcome; Vulvar Neoplasms

2014
Complete remission of two patients with recurrent and wide spread extramammary Paget disease obtained from 5-aminolevulinic acid-based photodynamic therapy and imiquimod combination treatment.
    Photodiagnosis and photodynamic therapy, 2014, Volume: 11, Issue:3

    Topics: Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Drug Therapy, Combination; Genital Neoplasms, Male; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photosensitizing Agents; Remission Induction; Skin Neoplasms; Treatment Outcome

2014
In transit recurrence of Merkel cell carcinoma associated with polyarthritis effectively treated with immunocryosurgery.
    Acta dermato-venereologica, 2014, Volume: 94, Issue:6

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arthritis; Carcinoma, Merkel Cell; Cryosurgery; Drug Administration Schedule; Female; Humans; Imiquimod; Immunotherapy; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Remission Induction; Skin Neoplasms; Treatment Outcome

2014
Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN 2/3.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:19

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Factors; Vulvar Neoplasms

2014
Imiquimod 5% cream for five consecutive days a week in an HIV-infected observational cohort up to 32 weeks in the treatment of high-grade squamous intraepithelial lesions.
    Sexually transmitted infections, 2015, Volume: 91, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Disease Progression; Electrocoagulation; Female; HIV Seropositivity; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Prospective Studies; Squamous Intraepithelial Lesions of the Cervix

2015
Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
    The British journal of dermatology, 2016, Volume: 174, Issue:1

    Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms

2016
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.
    The British journal of dermatology, 2016, Volume: 174, Issue:5

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Leg; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Treatment Outcome

2016
Subungual Melanoma In Situ Treated With Imiquimod 5% Cream After Conservative Surgery Recurrence.
    Journal of drugs in dermatology : JDD, 2017, Mar-01, Volume: 16, Issue:3

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Humans; Imiquimod; Male; Melanoma; Nails; Neoplasm Recurrence, Local; Skin Cream; Skin Neoplasms; Toes

2017
Imiquimod in vulvar Paget's disease: a case report.
    The Journal of reproductive medicine, 2008, Volume: 53, Issue:10

    Topics: Aged, 80 and over; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Remission Induction; Treatment Outcome; Vulvar Neoplasms

2008
Imiquimod treatment associated with a reduction in new skin cancer formation.
    Clinical and experimental dermatology, 2009, Volume: 34, Issue:1

    Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Skin Neoplasms

2009
Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
    Veterinary and comparative oncology, 2008, Volume: 6, Issue:1

    Topics: Aminoquinolines; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Imiquimod; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2008
Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:8

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Skin Neoplasms

2009
What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:11

    Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Frozen Sections; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Ointments

2009
Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
    Cutis, 2010, Volume: 85, Issue:4

    Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arsenic; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Neoplasm Recurrence, Local; Psoriasis; Skin Neoplasms

2010
Periocular lentigo maligna treated with imiquimod.
    The Journal of dermatological treatment, 2011, Volume: 22, Issue:2

    Topics: Aminoquinolines; Antineoplastic Agents; Eye Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2011
Failed treatment of amelanotic lentigo maligna with imiquimod followed by pigment production.
    Archives of dermatology, 2010, Volume: 146, Issue:9

    Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Melanoma, Amelanotic; Middle Aged; Neoplasm Recurrence, Local; Nose; Risk Assessment; Skin Neoplasms; Treatment Outcome

2010
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer.
    Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cryosurgery; Delayed Diagnosis; Epidermolysis Bullosa; Female; Fluorouracil; Homozygote; Humans; Imiquimod; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Periodontal Diseases; Photosensitivity Disorders; Skin Neoplasms

2010
[Surgical vs nonsurgical treatment of basal cell carcinoma].
    Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:8

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryosurgery; Fluorouracil; Follow-Up Studies; Hedgehog Proteins; Humans; Imiquimod; Interferons; Laser Therapy; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Phytotherapy; Plant Preparations; Risk Factors; Semecarpus; Skin Neoplasms; Treatment Outcome

2010
Re-inventing intratumoral immunotherapy for melanoma.
    Immunotherapy, 2011, Volume: 3, Issue:5

    Topics: Aminoquinolines; Antineoplastic Agents; BCG Vaccine; Cytokines; Humans; Imiquimod; Immunotherapy; Injections, Intralesional; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2011
Successful treatment of recurrent extramammary Paget's disease of the penis and scrotum with imiquimod 5% cream.
    Presse medicale (Paris, France : 1983), 2011, Volume: 40, Issue:12 Pt 1

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Gels; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Osmolar Concentration; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Treatment Outcome

2011
[Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
    Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:10

    Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Skin Neoplasms; Skin Ulcer

2011
Conservative management of extramammary paget disease with imiquimod.
    Journal of lower genital tract disease, 2012, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Neoplasms; Treatment Outcome; Vulva; Vulvar Neoplasms

2012
Treatment of locally recurrent mucosal melanoma with topical imiquimod.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-20, Volume: 29, Issue:33

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Vaginal Neoplasms; Vulvar Neoplasms

2011
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
    International journal of dermatology, 2012, Volume: 51, Issue:4

    Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms

2012
Vulvar intraepithelial neoplasia: evaluation of treatment modalities.
    Journal of lower genital tract disease, 2012, Volume: 16, Issue:3

    Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma in Situ; Cohort Studies; Female; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Imiquimod; Immunohistochemistry; Laser Therapy; Lasers, Gas; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Portugal; Retrospective Studies; Risk Assessment; Treatment Outcome; Vulvar Neoplasms; Young Adult

2012
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases.
    Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:7

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Paraffin Embedding; Reoperation; Retrospective Studies; Skin Neoplasms; Skin Pigmentation; Treatment Outcome

2012
Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.
    Gynecologic oncology, 2012, Volume: 127, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Vulva; Vulvar Neoplasms; Young Adult

2012
Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Dec-15, Volume: 18, Issue:24

    Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemoradiotherapy; Cyclophosphamide; Cytokines; Dose Fractionation, Radiation; Drug Synergism; Histocompatibility Antigens Class I; Humans; Imiquimod; Immunologic Memory; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Lymph Nodes; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; Neoplasm Transplantation; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Tumor Burden

2012
Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2013, Volume: 120, Issue:3

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Human papillomavirus 16; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papillomavirus Infections; Remission Induction; Retrospective Studies; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms

2013
Topical imiquimod in the treatment of metastatic melanoma to skin.
    Archives of dermatology, 2003, Volume: 139, Issue:3

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Knee; Leg; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Scalp; Skin Neoplasms; Treatment Outcome

2003
Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.
    Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:3

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms

2003
Extensive lentigo maligna clearing with topical imiquimod.
    Archives of dermatology, 2003, Volume: 139, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms

2003
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
    Archives of dermatology, 2003, Volume: 139, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Skin Neoplasms

2003
Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream.
    Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:4

    Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms

2003
Medical treatment of nasal squamous papilloma with imiquimod cream.
    The Journal of laryngology and otology, 2003, Volume: 117, Issue:9

    Topics: Aminoquinolines; Humans; Imiquimod; Immunity, Cellular; Immunocompromised Host; Interferon Inducers; Male; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Ointments; Papilloma; Treatment Outcome

2003
Locoregional cutaneous metastases of malignant melanoma and their management.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:2 Pt 2

    Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Lymphatic Metastasis; Male; Melanoma; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Skin Neoplasms; Treatment Outcome

2004
Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2 Suppl 1

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Recurrence, Local; Skin Neoplasms

2005
To the editor: incompletely excised basal cell carcinoma treated with 5% imiquimod cream.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:11 Pt 1

    Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms

2005
Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:1

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Nasal Cavity; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms

2007
Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:5

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Forehead; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms

2007
Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Cutis, 2007, Volume: 79, Issue:3

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2007
Treatment of locally metastatic melanoma: a novel approach.
    Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:8

    Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Imiquimod; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Skin Neoplasms; Treatment Outcome

2007
Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
    The Journal of reproductive medicine, 2000, Volume: 45, Issue:8

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Carcinoma in Situ; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Self Administration; Tumor Virus Infections; Vulvar Neoplasms

2000
Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod.
    The Journal of reproductive medicine, 2002, Volume: 47, Issue:5

    Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Disease-Free Survival; Female; Humans; Imiquimod; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Texas; Treatment Outcome; Vulvar Neoplasms

2002